- Home
- DV vs VKTX Comparison
DV vs VKTX Comparison
Compare DV & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DV
- VKTX
- Stock Information
- Founded
- DV 2008
- VKTX 2012
- Country
- DV United States
- VKTX United States
- Employees
- DV N/A
- VKTX N/A
- Industry
- DV Computer Software: Prepackaged Software
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- DV Technology
- VKTX Health Care
- Exchange
- DV Nasdaq
- VKTX Nasdaq
- Market Cap
- DV 2.4B
- VKTX 3.5B
- IPO Year
- DV 2021
- VKTX 2015
- Fundamental
- Price
- DV $15.56
- VKTX $33.71
- Analyst Decision
- DV Buy
- VKTX Strong Buy
- Analyst Count
- DV 18
- VKTX 13
- Target Price
- DV $18.92
- VKTX $86.92
- AVG Volume (30 Days)
- DV 1.8M
- VKTX 3.9M
- Earning Date
- DV 08-05-2025
- VKTX 07-23-2025
- Dividend Yield
- DV N/A
- VKTX N/A
- EPS Growth
- DV N/A
- VKTX N/A
- EPS
- DV 0.29
- VKTX N/A
- Revenue
- DV $681,128,000.00
- VKTX N/A
- Revenue This Year
- DV $16.02
- VKTX N/A
- Revenue Next Year
- DV $11.68
- VKTX N/A
- P/E Ratio
- DV $53.52
- VKTX N/A
- Revenue Growth
- DV 15.30
- VKTX N/A
- 52 Week Low
- DV $11.52
- VKTX $18.92
- 52 Week High
- DV $23.11
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- DV 55.74
- VKTX 65.27
- Support Level
- DV $15.41
- VKTX $32.02
- Resistance Level
- DV $16.12
- VKTX $35.40
- Average True Range (ATR)
- DV 0.43
- VKTX 1.70
- MACD
- DV -0.01
- VKTX 0.11
- Stochastic Oscillator
- DV 64.10
- VKTX 67.72
About DV DoubleVerify Holdings Inc.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.